Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for distinguishing individualized medication of losartan by mass spectrometry through detection products

A technology of mass spectrometry and products, applied in the direction of biochemical equipment and methods, measurement/testing of microorganisms, DNA/RNA fragments, etc., which can solve problems such as limitations

Inactive Publication Date: 2020-05-22
BIOYONG TECH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the method and kit provided by this invention patent can only detect polymorphic sites on the homocysteine ​​metabolism pathway, and cannot detect polymorphic sites not involved in homocysteine ​​metabolism , has limitations in clinical medication guidance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for distinguishing individualized medication of losartan by mass spectrometry through detection products
  • Method for distinguishing individualized medication of losartan by mass spectrometry through detection products
  • Method for distinguishing individualized medication of losartan by mass spectrometry through detection products

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0081] Example 1: Primer Design and Synthesis

[0082] The surrounding sequences of the target SNP of this kit are queried in the db_SNP (build 132) and Hapmap (Rel 28, Phase II + III, Aug 10) databases, and these sequences are used to design multiple PCR primers and single base extension primers.

[0083] The corresponding specific PCR primer core sequence (SEQ1a) and specific extension primer core sequence (SEQ1b) were designed for the polymorphic site of rs1057910 related to the discrimination of drug type. One pair of PCR primers and one extension primer constitute an independent reaction system: SEQ1a / b. In this independently performed reaction system, SEQ1a participates in an independent multiplex PCR reaction, and SEQ1b participates in a subsequent independent single-base extension reaction.

[0084] Related primers were synthesized at Sangon Bioengineering (Shanghai) Co., Ltd.

Embodiment 2

[0085] Embodiment 2: sample DNA extraction

[0086] A total of 10 DNA samples were collected from ordinary Chinese people, marked as A1-A10. Among them, sample collection, DNA extraction, etc. were collected in accordance with the requirements of the instructions, and human venous blood was collected with EDTA anticoagulant tubes. According to the instructions, the collected blood should not be stored at 2-8°C for more than one week, and at -20°C for no more than one month, and can be transported in a curling box with ice or a foam box with ice. It is recommended to use fresh blood as much as possible. Genomic DNA extraction. Since this kit does not provide human genomic DNA extraction reagents, a commercial nucleic acid extraction kit (such as QIAGEN’s DNeasy Blood and Tissuekit) was used to extract human genomic DNA from 200 μL of whole blood of each patient, and the DNA was extracted using a NanoDrop 2000 ( Thermo Company) quantified, and standardized to 30ng / μL (respecti...

Embodiment 3

[0087] Embodiment three: biological experiment

[0088] Use ABI 9700 type PCR instrument, according to the instruction manual to test the polymorphic sites and distinguish the drug type.

[0089] The components used in the kit for PCR, PCR product purification and single base extension are:

[0090] serial number component name main ingredient Specification 1 PCR Primer Mix PCR primers 24μl / tube x1 tube 2 PCR reaction solution Taq enzyme, dNTP 72μl / tube x1 tube 3 Enzyme digestion reaction solution SAP enzyme 48μl / tube x1 tube 4 Extension Primer Mix extension primer 24μl / tube x1 tube 5 Extension reaction solution Single base elongase, ddNTP 24μl / tube x1 tube 6 positive control Human Genomic DNA (30ng / μL) 10μL / tube x1 tube

[0091] The concentration of each primer pair is 500nmol / L.

[0092] According to the manual, the specific operation method is as follows:

[0093] 1. PCR amplification

[0094...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

As different single nucleotide polymorphism (SNP) sites have extension primers with different molecular weights and multiple sites are detected by Mass Array matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS), the invention can finally obtain a method for distinguishing the individualized medication of losartan by mass spectrometry through detection products. The method includes the steps of respectively designing multiple amplification primers and extension primers according to multiple to-be-detected target SNP sites; preparing a multiple amplification primer reaction system and an extension primer reaction system; simultaneously and respectively performing amplification and single base extension reaction on the multiple target SNP sites by usingmultiple sets of the primers in the reaction systems; and performing time-of-flight mass spectrometry on products after single base extension reaction, and identifying the genotypes of different drugmetabolism related SNP according to the products of the extension primers with different molecular weights represented by mass spectrum peaks so as to guide the medication of the antihypertensive druglosartan. The method can detect the SNP sites related to the metabolism of the antihypertensive drug losartan; and the method is low in cost, short in time consumption, simple and convenient in result analysis and extremely wide in application field and does not need to synthesize probes.

Description

technical field [0001] The invention belongs to the field of molecular biology detection, and relates to a method for detecting multiple PCR single-base extension products by using mass spectrometry characteristic peaks and its products. The method can simultaneously detect multiple PCR single-base extensions in two multiplex PCR reactions Amplified oligonucleotide products. More specifically, the method uses different time-of-flight mass spectrometry characteristic peaks generated by different target oligonucleotide fragments in the process of mass spectrometry typing, and simultaneously detects multiple target SNP sites to guide the antihypertensive drug Roxa Frank medication. Background technique [0002] Human genetic information is stored in the genome. In 2002, the Human Genome Project, an international cooperation project, was finally completed, drawing a fine map of the human genome structure and providing a reference sequence for related research. The human genome...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6883C12Q1/6858C12N15/11
CPCC12Q1/6858C12Q1/6883C12Q2600/106C12Q2600/156C12Q2600/16C12Q2531/113C12Q2537/143C12Q2533/101C12Q2565/627
Inventor 马庆伟刘昕超
Owner BIOYONG TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products